| OR (95% CL) | ||
---|---|---|---|
VARIABLE | BP at Target (< 130/80 mmHg) | Systolic BP at Target (< 130 mmHg) | Diastolic BP at Target (< 80 mmHg) |
INDIVIDUAL LEVEL-1 PATIENT FACTORS | |||
Predisposing characteristics | Â | Â | Â |
AGE | Â | Â | Â |
   < 55 years |  | --------------- | --------------- |
   55-64 years |  | 0.93 (0.54-1.60) | 1.87 (0.88-3.89) |
   65-74 years |  | 0.62 (0.32-1.18) | 3.56 (1.67-7.56)* |
   75 + years |  | 0.48 (0.25-0.96)* | 6.12 (2.66-14.12)* |
GENDER | Â | Â | Â |
   Male |  |  | --------------- |
   Female |  |  | 2.09 (1.03-4.25)* |
Evaluated Need | Â | Â | Â |
YEARS SINCE HYPERTENSION DIAGNOSIS | Â | Â | Â |
   In the past 5 years | --------------- |  |  |
   5 to 10 years ago | 1.62 (1.07-2.44)* |  |  |
   Over 10 years ago | 1.04 (0.67-1.60) |  |  |
   I do not remember | 1.12 (0.25-4.96) |  |  |
LIPIDS: LDL-CHOL | Â | Â | Â |
   Uncontrolled |  |  | --------------- |
   Controlled |  |  | 1.68 (1.14-2.49)* |
RENAL STATUS | Â | Â | Â |
   Missing | 0.52 (0.28-1.01) | 0.45 (0.23-0.87)* |  |
   Normal | --------------- | --------------- |  |
   Microalbuminuria | 1.10 (0.70-1.72) | 1.28 (0.79-2.07) |  |
Overt Nephropathy | 0.48 (0.33-0.69)* | 0.48 (0.31-0.76)* | Â |
Personal Health Practices | Â | Â | Â |
MEDICATION ADHERENCE | Â | Â | Â |
   High Adherence | --------------- | --------------- |  |
   Medium Adherence | 0.72 (0.50-1.04) | 0.80 (0.54-1.19) |  |
   Low Adherence | 0.29 (0.09-0.86)* | 0.34 (0.12-0.96)* |  |
   Missing | 1.65 (0.79-3.43) | 1.87 (0.92-3.82) |  |
BLOOD PRESSURE SELF-MONITORING | Â | Â | Â |
   No | --------------- | --------------- |  |
   Sometimes | 0.87 (0.58-1.30) | 0.79 (0.53-1.18) |  |
   Often | 0.51 (0.33-0.79)* | 0.47 (0.28-0.80)* |  |
EAT FOODS LOW IN SALT | Â | Â | Â |
   No | --------------- |  | --------------- |
   Yes | 1.74 (1.25-2.41)* |  | 2.35 (1.49-3.70)* |
NO CONTEXTUAL PHYSICIAN OR SYSTEM LEVEL-2 FACTORS WERE SIGNIFICANT IN THE HLM MODEL |